Searched for: person:caplaa01
Whole organ and tissue reconstruction in thoracic regenerative surgery
Lim, Mei Ling; Jungebluth, Philipp; Ajalloueian, Fatemeh; Friedrich, Linda Helen; Gilevich, Irina; Grinnemo, Karl-Henrik; Gubareva, Elena; Haag, Johannes C; Lemon, Greg; Sjoqvist, Sebastian; Caplan, Arthur L; Macchiarini, Paolo
Development of novel prognostic, diagnostic, and treatment options will provide major benefits for millions of patients with acute or chronic respiratory dysfunction, cardiac-related disorders, esophageal problems, or other diseases in the thorax. Allogeneic organ transplant is currently available. However, it remains a trap because of its dependency on a very limited supply of donated organs, which may be needed for both initial and subsequent transplants. Furthermore, it requires lifelong treatment with immunosuppressants, which are associated with adverse effects. Despite early clinical applications of bioengineered organs and tissues, routine implementation is still far off. For this review, we searched the PubMed, MEDLINE, and Ovid databases for the following keywords for each tissue or organ: tissue engineering, biological and synthetic scaffold/graft, acellular and decelluar(ized), reseeding, bioreactor, tissue replacement, and transplantation. We identified the current state-of-the-art practices in tissue engineering with a focus on advances during the past 5 years. We discuss advantages and disadvantages of biological and synthetic solutions and introduce novel strategies and technologies for the field. The ethical challenges of innovation in this area are also reviewed.
PMID: 24079685
ISSN: 0025-6196
CID: 611942
Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disorders
McCormack, Ryan P; Williams, Arthur R; Goldfrank, Lewis R; Caplan, Arthur L; Ross, Stephen; Rotrosen, John
PMID: 23602314
ISSN: 0140-6736
CID: 335292
Strands of Promise in Genetically Modified Food
Caplan, Arthur L
A 2013 poll in The New York Times found that three-quarters of Americans have concerns about genetically modified organisms (GMOs) in their food; most are worried about health effects. Thirty-seven percent of those with worries fear that GM foods cause cancer or allergies
PROQUEST:1431438280
ISSN: 0009-5982
CID: 1490062
The actress, the court, and what needs to be done to guarantee the future of clinical genomics
Caplan, Arthur L
Clinical genomics is poised for a rapid expansion but more work must be done to build a supporting ethical infrastructure.
PMCID:3782420
PMID: 24086107
ISSN: 1544-9173
CID: 574042
Singing the DSM-5 Blues
Caplan, Arthur L
Caplan cites some criticisms of the newly revised Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association--DSM-5. The DSM is often described as the bible of the mental health field--and unfortunate misnomer that leaves it open to attack as a compendium of divinely inspired truths about human behavior. The most common criticism in the reviews and books is that DSM-5 proliferates diseases beyond the boundaries of common sense
PROQUEST:1412271113
ISSN: 0272-0701
CID: 1496232
Deleting Memories [Editorial]
Caplan, Arthur
ISI:000321157500011
ISSN: 1099-274x
CID: 449962
Exempting schoolchildren from immunizations: States with few barriers had highest rates of nonmedical exemptions
Blank, Nina R; Caplan, Arthur L; Constable, Catherine
Rates of nonmedical exemptions from school immunizations are increasing and have been associated with resurfacing clusters of vaccine-preventable diseases, such as measles. Historically, state-level school immunization policies successfully suppressed such diseases. We examined state immunization exemption regulations across the United States. We assessed procedures for exempting schoolchildren and whether exemption rates were associated with the complexity of the procedures. We also analyzed legal definitions of religious objections and state legislatures' recent modifications to exemption policies. We found that states with simpler immunization exemption procedures had nonmedical exemption rates that were more than twice as high as those in states with more-complex procedures. We also found that the stringency of legal definitions of religious exemptions was not associated with exemption procedure complexity. Finally, we found that although there were more attempts by state legislatures to broaden exemptions than to tighten them in 2011-13, only bills tightening exemptions passed. Policy makers seeking to control exemption rates to achieve public health goals should consider tightening nonmedical exemption procedures and should add vaccine education components to the procedures by either mandating or encouraging yearly educational sessions in schools for parents reluctant to have their children vaccinated.
PMID: 23836745
ISSN: 0278-2715
CID: 508962
The OHRP and SUPPORT [Letter]
Wilfond, Benjamin S; Magnus, David; Antommaria, Armand H; Appelbaum, Paul; Aschner, Judy; Barrington, Keith J; Beauchamp, Tom; Boss, Renee D; Burke, Wylie; Caplan, Arthur L; Capron, Alexander M; Cho, Mildred; Clayton, Ellen Wright; Cole, F Sessions; Darlow, Brian A; Diekema, Douglas; Faden, Ruth R; Feudtner, Chris; Fins, Joseph J; Fost, Norman C; Frader, Joel; Hester, D Micah; Janvier, Annie; Joffe, Steven; Kahn, Jeffrey; Kass, Nancy E; Kodish, Eric; Lantos, John D; McCullough, Laurence; McKinney, Ross Jr; Meadow, William; O'Rourke, P Pearl; Powderly, Kathleen E; Pursley, DeWayne M; Ross, Lainie Friedman; Sayeed, Sadath; Sharp, Richard R; Sugarman, Jeremy; Tarnow-Mordi, William O; Taylor, Holly; Tomlinson, Tom; Truog, Robert D; Unguru, Yoram T; Weise, Kathryn L; Woodrum, David; Youngner, Stuart
PMID: 23738513
ISSN: 0028-4793
CID: 464212
Accepting a helping hand can be the right thing to do
Caplan, Arthur
PMID: 22942371
ISSN: 0306-6800
CID: 202642
Risk, Consent, and SUPPORT
Magnus, David; Caplan, Arthur L
Comparative effectiveness research has the potential to dramatically improve patient care while reducing costs. In the absence of good evidence about which treatment is best for particular patients, decision making too often hinges on exogenous factors such as advertising and detailing by pharmaceutical companies, what a physician first learned to do, insurance coverage, and local custom. Without good evidence about what is best among competing but generally accepted clinical options, it is often a challenge for physicians to identify the best course of care. A great deal of effort is under way to make it easier and less expensive to . . .
PMID: 23597408
ISSN: 0028-4793
CID: 336132